LOADING
Comparing Johnson & Johnson (JNJ) and Intel Corporation (INTC) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | INTC |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $537.4B | $566.5B |
| P/E Ratio | 25.8 | -- |
| Forward P/E | 19.3 | 135.1 |
| PEG Ratio | 2.90 | 1.36 |
| EPS | $8.64 | $-0.60 |
| Revenue Growth (YoY) | 9.9% | 7.2% |
| Profit Margin | 21.8% | -5.9% |
| Return on Equity | 26.4% | -2.9% |
| Dividend Yield | 2.33% | -- |
| Beta | 0.26 | 2.19 |
| 52-Week High | $250.24 | $132.75 |
| 52-Week Low | $145.39 | $18.96 |
| Volume | -- | -- |
Intel Corporation is the larger company by market capitalization. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.